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Available online 3 December 2012Abstract Mesenchymal stem cells (MSCs) can differentiate into several distinct cell types, including osteoblasts and
adipocytes. The balance between osteogenic and adipogenic differentiation is disrupted in several osteogenic-related
disorders, such as osteoporosis. So far, little is known about the molecular mechanisms that drive final lineage commitment
of MSCs. In this study, we revealed that miR-17-5p and miR-106a have dual functions in the modulation of human
adipose-derived mesenchymal stem cells (hADSCs) commitment by gain- and loss-of-function assays. They could promote
adipogenesis and inhibit osteogenesis. Luciferase reporter assay, western blot and ELISA suggested BMP2 was a direct target
of miR-17-5p and miR-106a. Downregulation of endogeneous BMP2 by RNA interference suppressed osteogenesis and increased
adipogenesis, similar to the effect of miR-17-5p and miR-106a upregulation. Moreover, the inhibitory effects of miR-17-5p on
osteogenic and adipogenic differentiation of hADSCs could be reversed by BMP2 RNA interference. In conclusion, miR-17-5p and
miR-106a regulate osteogenic and adipogenic lineage commitment of hADSCs by directly targeting BMP2, and subsequently
decreased osteogenic TAZ, MSX2 and Runx2, and increased adipogenic C/EBPα and PPARγ.
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binding proteins alpha; PPARγ, peroxisome proliferator-activated receptor gamma; LPL, lipoprotein lipase; AP2 (FABP4), fatty acid binding
protein 4, adipocytes; ID1, helix-loop-helix proteins1.
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Human mesenchymal stem cells (hMSCs) have multilineage
differentiation potential. These cells can differentiate to
form a variety of tissues such as bone, cartilage, adipose and
endothelium (Cao et al., 2005; Phinney and Prockop, 2007;
Pittenger et al., 1999; Reyes et al., 2001; Fink et al., 2011).
The balance between osteogenic and adipogenic differen-
tiation of human mesenchymal stem cells is disrupted in
various human diseases. For example, decreased bone forma-
tion accompanied by an increase in bone marrow adipogenesis
occurs with aging, immobility or osteoporosis (Kajkenova
et al., 1997; Nuttall and Gimble, 2000), whereas increased
bone formation or calcification is observed in progressive
osseous hyperplasia (Bostrom et al., 1993; Kaplan and Shore,
2000; Parhami and Demer, 1997). Therefore, elucidation of
the molecular mechanisms regulating adipogenic and osteo-
genic differentiation of MSCs is of extreme importance for
finding new treatments of these diseases.
Adipogenesis is a highly regulated process in which a
coordinated cascade of transcription factors leads to the
formation of mature adipocytes (Rosen et al., 2000; Sethi
and Vidal-Puig, 2007). This cascade begins with the transient
expression of C/EBPβ and C/EBPδ which activate C/EBPα
and PPARγ. C/EBPα and PPARγ together coordinate the
expression of adipogenic genes underlying the phenotype of
terminally differentiated adipocytes. Osteogenesis is also a
highly coordinated process and is initiated by the transcrip-
tion factors Runx2 and Osterix (OSX), which lead to the
terminal osteoblast phenotype characterized by calcifica-
tion of the extracellular matrix. The genes involved in this
mineralization process include alkaline phosphatase (ALP)
and osteopontin (OPN) in early phase, and osteocalcin (OCN)
in late differentiation phase (Gallea et al., 2001; Jaiswal
et al., 1997; Nakashima and de Crombrugghe, 2003).
Mounting evidence showed that multiple pathways are
involved in regulating osteogenesis and adipogenesis, such as
TGFβ/BMPs/Smads, Wnt/β-catenin, Notch, JAK/STAT, MAPK,
PI3K/Akt and Hedgehog pathways (Bellido et al., 1997; Chiba,
2006; Fritzius and Moelling, 2008; Gallea et al., 2001; Ross
et al., 2000; Suh et al., 2006; ten Dijke et al., 2003). But
what factors are involved and how they orchestrate to regu-
late the specification of cell fate remain elusive. Therefore,
investigating the mechanisms that fine-tune the balance
between osteogenic and adipogenic differentiation of MSCs is
of high importance. Recent study revealed gene repression
to be most prevalent prior to commitment in osteogenesis
and adipogenesis, and computational analysis suggested that
gene repression before commitment is mediated by miRNAs
(Scheideler et al., 2008).
Recently, emerging evidence suggests that miRNAs are
involved in regulating differentiation and cell fate decisions
(Ivey and Srivastava, 2010). miR-196a, -29b, -2861, -3960 and
-335-5p were reported to enhance the osteogenic differenti-
ation (Hu et al., 2011; Kim et al., 2009; Li et al., 2009; Zhang
et al., 2011a), miR-26a, -133, -135, -141 and -200a could
impede osteogenic differentiation (Itoh et al., 2009; Li et al.,
2008; Luzi et al., 2008), and miR-143, -24, -31, -30c and
-642a-3pwere involved in regulating adipogenesis (Esau et al.,
2004; Sun et al., 2009; Yang et al., 2011; Zaragosi et al.,
2011). But so far, only a few key miRNAs controlling the
balance between osteogenesis and adipogenesis had beenidentified, such as miR-22 and miR-637 (Huang et al., 2012;
Zhang et al., 2011b).
In this study, we found that miR-17-5p and miR-106a
regulate lineage specification of hADSCs between osteo-
genesis and adipogenesis by directly targeting BMP2. These
miRNAs, as post-transcriptional regulators of osteogenic and
adipogenic differentiation, may serve as novel therapeutic
agents for osteogenesis- or adipogenesis-related disorders.
Materials and methods
Isolation and expansion of MSCs from adult human
adipose tissue
Human adipose tissue was obtained from donors undergoing
liposuction according to procedures approved by the Ethics
Committee at the Chinese Academy of Medical Sciences and
Peking Union Medical College. The isolation and culture
procedure of Cao et al. (2005) was adopted.
Osteogenic differentiation
The culture-expanded cells of 3rd passage at 80% confluence
were induced in the following osteogenic medium for 8 days:
high-glucose Dulbecco's modified Eagle's medium (H-DMEM)
supplemented with 10% FCS, 10 mM β-glycerophosphate, 10 nM
dexamethasone, and 0.2 mM ascorbic acid. The expression of
the osteogenic phenotype was evaluated after induction by
the simultaneous monitoring expression of genes involved in
osteogenic differentiation (qRT-PCR) and mineralization (ALP
and alizarin red staining). Eight days after osteogenic induction,
~70% of hADSCs showed an osteoblast-like phenotype.
Adipogenic differentiation
The culture-expanded cells of 3rd passage at 100% confluence
were induced in the following adipogenic medium for 8 days:
H-DMEM supplemented with 10% FCS, 1 μM dexamethasone,
0.5 mM isobutylmethylxanthine, and 1 mM ascorbic acid.
Adipogenesis was determined by oil red O staining. All reagents
used in osteogenic and adipogenic differentiation were from
Sigma Aldrich.
ALP, oil red O, and alizarin red staining
For detection of calcification during osteogenic differen-
tiation, the induced cells in 24-well plates were washed
twice with PBS and fixed with 95% ethanol (500 μl/well) for
20 min. The fixed cells were stained with 1 ml of alizarin red
solution (Sigma) in each well and incubated in 37 °C for
30 min. The procedure of ALP staining was performed
according to the manufacturer's instructions of ALP staining
Kit (Institute of Hematology & Blood Diseases Hospital,
Chinese Academy of Medical Sciences). For oil red O
staining, cells were washed twice with PBS and fixed with
10% formalin for 10 min at room temperature. After fixation,
cells were stained with filtered oil red O solution (stock
solution: 3 mg/ml in isopropanol; working solution: 60% oil
red O stock solution and 40% distilled water) for 1 h at room
temperature. After staining, cells were washed with water
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photographed. In order to quantify the degree of adipogenic
differentiation, after visualized by light microscopy, the
dye in cells was extracted with isopropanol and OD value was
measured at 510 nm wavelength.
MiRNA profiling analysis
miRNA profiling was performed by high-throughput quantita-
tive qRT-PCR using the TaqMan® Array Human MicroRNA Cards
V3.0 (Applied Biosystems) following the manufacturer's in-
structions. Ten nanograms of total RNA was used for each
reaction. PCRs were repeated at least twice, and the mean
relative expression level was calculated. The U6 was used for
data normalization (Applied Biosystems). Experiments were
performed in triplicate.
MiRNA mimic, miRNA inhibitor, and
siRNA transfection
Human ADSCs were transfected with liprofectamine2000
(Invitrogen) according to the manufacturer' procedures
before differentiation. All oligonucleotides were obtained
from GenePharma (Shanghai, China). Transfection efficiency
was assessed by percentage of fluorescent-positive cells
under fluorescence microscope 24 h after transfection. Cells
were induced and harvested at various time points for
protein and mRNA assays.
RNA-reverse transcription and qRT-PCR
Total RNA was extracted using Trizol total RNA isolation
reagent (Invitrogen) and purified with the Column DNA
Erasol kit (TianDz, Beijing, China) according to the manu-
facturer's instructions. qRT-PCR was carried out to check
mRNA levels with SYBR Green I (TaKaRa). The expression
level of genes was normalized to GAPDH. All experiments
were performed in triplicate. Primers used for amplification
are listed in supplemental Table 1. Reverse transcription of
miRNAs was performed with miScript Reverse Transcription
Kit (Qiagen, Shanghai, China). Expression of mature miRNAs
was determined using miRNA-specific quantitative qRT-PCR
(TaKaRa). The expression levels were normalized to U6, an
internal control, and measured by comparative Ct (ΔΔCt)
method.
DNA constructs, reporter plasmids, and luciferase
assays
Putative miR-17 family-recognition element from the BMP2
gene was cloned in the 3′-UTR of the firefly luciferase
reporter vector according to the manufacturer's guidelines.
The oligonucleotide sequences were designed to carry the
Xba1 and Not1 sites at their ends to facilitate ligation into
corresponding sites of pRL-TK-Report (Promega). The oligo-
nucleotides used in these studies are showed in supple-
mental Table 2. For luciferase activity assay, 5.0×104 cells
in 24-well plates were cotransfected with 0.5 μg of the
indicated pRL-TK firefly luciferase construct and 40 ng of a
PGL3 renilla luciferase normalization control, together with200 nM miR-17-5p and miR-106a mimic or their inhibitor, or
its corresponding control. Luciferase assays were performed
48 h after transfection using the Dual Luciferase Reporter
Assay System (Promega). Firefly luciferase activity was
normalized to renilla luciferase activity for each transfected
well. All experiments were done thrice in triplicate.Western blot, ELISA and antibodies
Cells were harvested in RIPA lysis buffer (Beyotime,
Shanghai, China). Whole cell protein extracts were qualified
by BCA assay. Proteins from total cell lysates were separated
onto NuPAGE 12% polyacrylamide gels (Invitrogen), trans-
ferred to nitrocellulose membranes (Bio-Rad), blocked in 5%
non-fat milk in TBST, and hybridized with antibodies for
BMP2 (1:500, Abcam), TAZ (1:500, LifeSpan Biosciences),
MSX2 (1:125, Millipore), Runx2 (1:100, CST), ALP (1:3000,
Abcam), OPN (1:500, Abcam), C/EBPα (1:5000, Abcam),
PPARγ (1:1000, CST) and AP2 (1:1000, Millipore) respective-
ly. Actin (1:500, Abcam) or GAPDH (1:1000, Cell Biolabs) on
the same membrane was used as a loading control. Signals
were revealed after incubation with anti-rabbit IgG second-
ary antibody (1:1500) or anti-mouse IgG secondary antibody
(1:2000) coupled to peroxidase by using ECL (Amersham
Biosciences). ELISA array for BMP2 protein was carried out
according to the manufacturer's instructions (NeoBioscience,
EHC172.96).Data analysis
All results are presented as means±SEM. Comparisons
between groups were analyzed using t-tests (two-sided).
Differences with p values of less than 0.05 were considered
significant. The p values were corrected for multiple testing
procedures and to control type I error rates.Results
Expression of miRNA-17 family members during
osteogenesis and adipogenesis of hADSCs
Human adipose-derived mesenchymal stem cells (hADSCs)
were isolated and phenotyped. They were positive for
adhesion molecules CD29, CD44, CD105 and CD166 (N95%)
and negative for CD31, CD34, CD45 and HLA-DR (b5%)
(Fig. 1A). Expression levels of a panel of 740 miRNAs were
determined by high-throughput quantitative RT-PCR during
either osteogenic differentiation or adipogenic differentia-
tion. Results showed the expression levels of miRNA-17 family,
including miR-17-5p, -106a and -20a were downregulated
when hADSCs underwent differentiation toward osteogenic
lineages, but upregulated during adipocyte differentiation
(Fig. 1B). Downregulation of miR-17-5p and miR-106a during
osteogenesis has been reported by Li et al. (2008). Therefore
we speculated that miR-17-5p and miR-106a might be crucial
regulators of osteogenic and adipogenic differentiation of
hADSCs. These results were confirmed by miRNA specific
qRT-PCR at days 0, 2, 4, 6, and 8 after either osteogenic or
adipogenic differentiation of hADSCs (Fig. 1C).
Figure 1 miR-17 family member expression profile during adipogenic and osteogenic differentiation of hADSCs. (A) Phenotypic
analysis of hADSCs by flow cytometry. (B) miRNA profile during adipogenesis and osteogenesis of hADSCs was detected by TaqMan®
Array Human MicroRNA Cards V3.0. Total RNA was extracted at day 3 or day 4 in hADSCs undergoing adipogenic and osteogenic
differentiation, respectively. (C) Dynamic expression level of miR-17-5p and miR-106a in osteogenesis and adipogenesis of hADSCs
was indicated by qRT-PCR. miR-17-5p is abbreviated as 17-5p, the others are similarly abbreviated. U6 was used for miRNA
data normalization. Relative miRNA levels are represented as mean±SEM, n=3. The significance difference is noted as ***, pb0.001;
**, pb0.01; *, pb0.05, respectively.
316 H. Li et al.
miR-17-5p and miR-106a in osteogenic and adipogenic differentiation 317Overexpression of miR-17-5p and miR-106a
suppresses osteogenesis but promotes adipogenesis
of hADSCs
To elucidate the roles of miR-17-5p and miR-106a during
hADSCs differentiation, synthetic mimics of those miRNA
were transfected into hADSCs. The concentration of 200 nM
was used in the experiment because transfection efficiency
was highest at this concentration at 24 h after transfection
and the transfected hADSCs exhibited no morphological
changes compared to naive or miR-NC (negative control)-
transfected groups (Supplemental Fig. 1A). qRT-PCR analysis
showed that the expression of miR-17-5p and miR-106a
increased by 5.8-fold and 6.1-fold in hADSCs transfected with
these miRNA's mimics respectively (Supplemental Fig. 1B).
Next miR-17-5p and miR-106a-overexpressing hADSCs were
induced to differentiate toward either adipogenic or osteo-
genic lineages. Results showed that overexpression of
miR-17-5p and miR-106a significantly inhibited osteogenic
differentiation as indicated by ALP activity, alizarin red
staining for mineralization and expression of the osteogenic
transcription factors Runx2 and OSX, and osteoblast marker
ALP and OPN at early stage, OCN at late stage (Fig. 2A–C). On
the contrary, overexpression of these miRNAs promoted
adipogenesis as indicated by oil red O staining and expression
of adipocytic differentiation-related genes C/EBPα, PPARγ,
AP2 and LPL (Fig. 2D–F).Inhibition of endogenous miR-17-5p and miR-106a
promotes osteogenic differentiation and suppresses
adipogenic differentiation of hADSCs
To further evaluate the roles of miR-17-5p and miR-106a
on hADSC differentiation, miR-17-5p and miR-106a specific
inhibitor (miR-17-5pI and miR-106aI) were transfected into
hADSCs to inhibit endogenous expression. miRNA specific
qRT-PCR showed that transfection of inhibitors of those
miRNAs effectively inhibited their expression in hADSCs, com-
pared with negative control inhibitor (miR-NCI)-transfected
group (Supplemental Fig. 1C). hADSCs were then induced to
differentiate toward osteogenic and adipogenic lineages.
Treatment of hADSCs by either miR-17-5p or miR-106a inhib-
itor significantly increased ALP activity, alizarin red staining,
expression of osteogenic transcription factors (Runx2 and OSX)
and marker genes (ALP and OPN at early stage, OCN at late
stage) at mRNA and protein levels, indicating that down-
regulation of either miR-17-5p or miR-106a might promote
osteogenesis of hADSCs (Fig. 3A–C). On the contrary, treat-
ment of hADSCs by either miR-17-5p or miR-106a inhibitor sig-
nificantly decreased oil red O staining, expression of adipogenic
transcription factors (C/EBPα and PPARγ) and marker genes
(LPL and AP2) at mRNA and protein levels, indicating that
downregulation of eithermiR-17-5p ormiR-106amight suppress
adipogenesis of hADSCs (Fig. 3D–F).BMP2 is the target of miR-17-5p and miR-106a
As a first step to investigate the mechanisms underlying the
actions of the miR-17-5p and miR-106a on hADSCs differen-
tiation, we focused on identifying the potential targets ofmiR-17-5p and miR-106a. Because miR-17-5p and miR-106a
were downregulated during osteogenesis, we expected that
the expression of their target genes should be concomitantly
upregulated. qRT-PCR analysis showed that the expression
levels of BMP2, TAZ, MSX2, BMPR2, BMPR1B and Smad5
gradually increased when hADSCs were induced to differenti-
ate toward osteogenesis, and decreased during adipogenesis
(Fig. 4A and B). Especially, the expression patterns of BMP2,
TAZ andMSX2were negatively correlative with the expression
of miR-17-5p and miR-106a. BMP2 had been proved to con-
tribute to cell fate determination through regulating TAZ
and MSX2 (see in discussion), and bioinformatic analysis
(TargetScan and PicTar) indicated that BMP2 is a candidate
target of miR-17 family members. Thus we focused on BMP2
as a potential target of miR-17-5p and miR-106a. Indeed,
overexpression of miR-17-5p and miR-106a had no effect on
BMP2 at mRNA level, but decreased BMP2 at protein level
(Fig. 5A and B), indicating post-transcriptional regulation of
BMP2 by those miRNAs. miR-17-5p and miR-106a, belonging
to miR-17 family, have the same ‘seed sequence’, and
regulate a similar set of genes (Lim et al., 2003; Ye et al.,
2008). We further verified these results by using luciferase
reporters which contained either wild-type (pRL-TK-BMP2-WT)
or mutated (pRL-TK-BMP2-MUT) putative 3′UTR sequence for
BMP2-binding (miR-17 family ‘seed sequence’) in the 3′UTR
of the luciferase gene (Fig. 5C). Overexpression of miR-17-5p
and miR-106a significantly suppressed luciferase activity
of pRL-TK-BMP2-WT reporter plasmid but not that of pRL-TK-
BMP2-MUT reporter plasmid (Fig. 5C). Inhibition of either
miR-17-5p or miR-106a by co-transfection of their inhibitors
(miR-17-5pI and miR-106aI, respectively) increased the lucif-
erase activity of pRL-TK-BMP2-WT in hADSCs compared with
inhibitor negative control (miR-NCI) (Fig. 5D).miR-17-5p and miR-106a regulate lineage
specification of hADSCs via BMP2
Furthermore, in order to confirm that the effect of miR-
17-5p and miR-106a during hADSCs differentiation is medi-
ated by BMP2, we used a specific siRNA (siBMP2) to knock-
down endogenous BMP2. The efficiency of siRNAs for BMP2
was verified by qRT-PCR and western blot (Fig. 6A). ALP
assay, alizarin red staining for mineralization and qRT-PCR
for lineage-related genes all indicated that downregulation
of endogenous BMP2 hampered osteogenesis. On the contrary,
downregulation of endogenous BMP2 promoted adipogenesis
of hADSCs as indicated by oil red O staining for lipids and
qRT-PCR for adipogenic lineage-related genes (Fig. 6B and C).
These results were consistent with those seen in miR-17-5p
andmiR-106amimic-transfected hADSCs.We then transfected
siBMP2 into miR-17-5p depleted hADSCs and found that the
effects of miR-17-5p inhibition on osteogenesis and adipo-
genesis of hADSCs could be significantly reversed by BMP2 RNA
interference, as demonstrated by ALP assay and alizarin red
staining for mineralization and oil red O staining for lipids
respectively (Fig. 6D).
To further confirmed that miR-17-5p and miR-106a pro-
mote adipogenesis and inhibit osteogenesis via BMP2 signal
pathway, we examined the expression levels of TAZ, MSX2
and ID1, which were reported to be the downstream targets
of BMP2 (Hong et al., 2005; Korchynskyi and ten Dijke, 2002;
Figure 2 Overexpression ofmiR-17-5p andmiR-106a in hADSCs inhibits osteogenesis and enhances adipogenic differentiation. (A) ALP and
alizarin red staining for mineralization indicated the effect of miR-17-5p andmiR-106a overexpression on hADSCs osteogenic differentiation
for day 6 and day 14, respectively. (B) Runx2, ALP and OPN protein level were detected by western blot. ALP positive cell number was
analysis by image pro plus 6.0 and normalized by total cell number. (C) miR-17-5p and miR-106a overexpression in hADSCs suppressed
osteogenic gene transcription according to qRT-PCR at day 6 during osteogenesis. (D) Oil red O staining indicated the effect of miR-17 family
overexpression on hADSCs adipogenic differentiation for day 8. (E) C/EBPα, PPARγ and AP2 protein level were detected by western blot. Oil
red O staining was extracted by isopropanol and quantified by OD value at 510 nm wavelength. (F) Overexpression of miR-17-5p and
miR-106a in hADSCs increased adipogenic gene transcription according to qRT-PCR at day 6 during adipogenesis. miRNA mimic's negative
control is abbreviated as NC, the other analogy. RelativemRNA levels are represented asmean±SEM. GAPDHwas used formRNA and protein
data normalization. Data are presented as a mean with a standard error from three independent repeats. A Student's T test was performed
for a control and the treatment. The significance difference is noted as ***, pb0.001; **, pb0.01; *, pb0.05, respectively.
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Figure 3 Inhibition of endogenous miR-17-5p and miR-106a in hADSCs increases osteogenesis and decreases adipogenic
differentiation. (A) Downregulation of miR-17-5p and miR-106a expression in hADSCs promotes osteogenic differentiation as
confirmed by ALP and alizarin red staining for day 6 and day 14, respectively. (B) Runx2, ALP and OPN protein level were detected by
western blot. ALP positive cell number was analysis by image pro plus 6.0 and normalized by total cell number. (C) Downregulation of
miR-17-5p and miR-106a expression in hADSCs promotes osteogenic gene levels as detected by qRT-PCR at day 6 during osteogenesis.
(D) Oil red O staining indicated the suppressive affect of miR-17-5p and miR-106a downregulation on adipogenic differentiation of
hADSCs for day 8. (E) C/EBPα, PPARγ and AP2 protein level were detected by western blot. Oil red O staining was extracted by
isopropanol and quantified by OD value at 510 nm wavelength. (F) miR-17-5p and miR-106a downregulation in hADSCs decreases
adipogenic gene transcription as confirmed by qRT-PCR at day 6 during adipogenesis. miRNA inhibitor's negative control is
abbreviated as NCI, the other analogy. Relative mRNA levels are represented as mean±SEM. GAPDH was used for mRNA and protein
data normalization. Data are presented as a mean with a standard error from three independent repeats. A Student's T test was
performed for a control and the treatment. The significance difference is noted as ***, pb0.001; **, pb0.01; *, pb0.05,
respectively.
miR-17-5p and miR-106a in osteogenic and adipogenic differentiation 319Lopez-Rovira et al., 2002; Matsubara et al., 2008). Western
blot showed that the expression levels of TAZ and MSX2
decreased when BMP2 was downregulated by siBMP2, but
the expression level of ID1 protein showed no significant
change (date not show). miR-17-5p overexpression also
decreased the protein levels of TAZ, MSX2 and osteogenic
Runx2, and increased the protein levels of adipogenicC/EBPα and PPARγ, similar to downregulation of endog-
eneous BMP2. Again, miR-17-5p knockdown had opposite
effects (Fig. 6E). These results suggested that the regulation
of BMP2-induced cell fate specification between osteogen-
esis and adipogenesis of hADSCs by miR-17-5p and miR-106a
is probably carried out via TAZ/MSX2-Runx2/PPARγ pathway
(Fig. 7).
Figure 4 Expression pattern of BMP2/Smad5 pathway during osteogenic and adipogenic differentiation of hADSCs. (A and B)
qRT-PCR analyzed the dynamic expression of BMP2/Smad5 pathway components in hADSCs during osteogenic and adipogenic
differentiation at 0, 2, 4, 6, and 8 days respectively. Relative mRNA levels are represented as mean±SEM. GAPDH was used for mRNA
data normalization. Data are presented as a mean with a standard error from three independent repeats. A Student's T test was
performed for a control and the treatment. The significance difference is noted as ***, pb0.001; **, pb0.01; *, pb0.05, respectively.
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Osteogenesis and adipogenesis of MSCs maintain a homeo-
stasis under physiological conditions. Once the homeostasis
of osteogenic and adipogenic differentiation of MSCs are
disrupted, disorders such as osteoporosis may occur. But
what factors are involved and how they orchestrate to regu-
late the specification of cell fate remain elusive. Recently,
Scheideler et al. (2008) found that gene repression to be
most prevalent prior to commitment in both lineages, and
computational analysis suggested that gene repression
before commitment of MSCs is mediated by miRNAs.
In this study, we found that several members of miR-17
family including miR-17-5p and miR-106a were downregulated
during differentiation of hADSCs toward osteogenic lineage,
but upregulated during adipogenesis. Enhanced level of
miR-17-5p and miR-106a promoted adipogenesis of hADSCs,
and inhibited osteogenic differentiation, whereas knockdown
one of them had opposite effects.
MiR-17 family is composed of six miRNAs (miR-17-5p,
-20a, -106a, -20b, 106b, and -93) which are derived from
miR-17-92 cluster and its two paralogues (Mendell, 2008),
and have same ‘seed sequence’ that has been verified as
an important element for mRNA targeting (Lim et al.,
2003; Ye et al., 2008). Recently, several members of the
miR-17 family have been identified to be specifically ex-
pressed in either undifferentiated or differentiating em-
bryonic stem cells (Houbaviy et al., 2003; Suh et al., 2004;
Tang et al., 2006). These miRNAs were also found to playan important role in early mammalian development,
hematopoietic and adipocytic differentiation (Foshay and
Gallicano, 2009; Garzon et al., 2006; Ventura et al., 2008;
Wang et al., 2008). More recently, miR-20a was reported
to be a regulator of osteogenic differentiation of human
MSCs by co-regulating BMP signaling (Zhang et al., 2011c).
Our data showed that other two important members of
miR-17 family, miR-17-5p and miR-106a, can suppress
osteogenic differentiation and promote adipogenic differ-
entiation of hADSCs.
To elucidate the mechanisms underlying the actions of
miR-17-5p and miR-106a on hADSCs differentiation, we
detected the expression of osteoblastic and adipocytic related
genes during hADSCs differentiation and found that the
expression level of BMP2, TAZ and MSX2 mRNA peaked after
4 days of osteogenic induction and then gradually decreased,
which is consistent with the recent finding that BMP2 was
involved in the earliest steps of osteogenesis (Tsuji et al.,
2006). These expression patterns were inversely correlated
with those of miR-17-5p and miR-106a during hADSCs differ-
entiation. As a member of TGFβ/BMPs pathway, BMP2 has
been shown to be involved in osteogenesis, fracture healing,
and bone formation (Cohen, 2002). BMP2 can determine
the differentiation process of MSCs through activating Runx2-
dependent gene transcription and repressing PPARγ-
dependent gene transcription (Cheng et al., 2003; Foshay
and Gallicano, 2009; Hong et al., 2005; Peng et al., 2004).
Based on bioinformatics analysis that indicated BMP2 is a
potential target ofmiR-17-5p andmiR-106a, we overexpressed
Figure 5 Prediction and confirmation of the direct target for miR-17-5p and miR-106a regulating hADSCs differentiation.
(A) qRT-PCR detected the effect of miR-17-5p and miR-106a on the expression of BMP2mRNA level at indicated times. (B) ELISA array
analyzed the BMP2 protein level on different treatment groups. (C) Target sequence and mutant of miR-17-5p and miR-106a on BMP2
3′UTR. (D) Identification of the relationship between miR-17-5p and miR-106a and BMP2 using double luciferase reporter system. NC
abbreviated as miR-NC transfected group; 17-5p: miR-17-5p transfected group; the other analogy. Relative mRNA/protein levels are
represented as mean±SEM. GAPDH was used for mRNA data normalization. Data are presented as a mean with a standard error from
three independent repeats. A Student's T test was performed for a control and the treatment. The significance difference is noted as
***, pb0.001; **, pb0.01; *, pb0.05, respectively.
miR-17-5p and miR-106a in osteogenic and adipogenic differentiation 321miR-17-5p and miR-106a and found that upregulation of either
miR-17-5p or miR-106a decreased BMP2 expression at protein
level. In addition, inhibition of either miR-17-5p or miR-106a
increased BMP2 expression, strongly suggesting that BMP2 is a
direct target gene of miR-17-5p and miR-106a during osteo-
genic and adipogenic differentiation of hADSCs.
Then, we demonstrated that both miR-17-5p and miR-106a
directly targeted the 3′UTR region of BMP2 by luciferase
reporter assay. Recently, miRNAs with similar ‘seed sequence’
have been reported to regulate a similar set of genes and have
overlapping functions (Foshay and Gallicano, 2009; Ventura
et al., 2008). In this study, we found that although miR-106a
and miR-17-5p possess the same ‘seed sequence’, miR-106a
mimic was less effective than miR-17-5p mimic in down-
regulating BMP2 in luciferase activity assay suggesting that
nucleotide sequences other than ‘seed sequence’ may con-
tribute to the difference of targeting efficiency in the same
miRNA family. This might be one of the reasons that different
members of miR-17 family showed different efficiency in
regulating osteogenic and adipogenic differentiation. Forinstance,miR-17-5p canmore effectively regulate adipogenesis
and osteogenesis than miR-106a.
Furthermore,we found that downregulation of endogeneous
BMP2 suppressed osteogenesis and increased adipogenesis,
similar to the effect of miR-17-5p or miR-106a overexpression.
Moreover, inhibitory effects of miR-17-5p and miR-106a on
osteogenesis and adipogenesis of hADSCs could be reversed by
BMP2 RNA interference. These results further indicated that
miR-17-5p andmiR-106a promote adipocyte differentiation and
suppress osteogenesis directly by negatively regulating BMP2.
MSX2, TAZ, and ID1 have been identified as candidate
genes regulated by BMP2 and are involved in the switch
between adipocyte and osteoblast differentiation. We found
thatmiR-17-5p overexpression was accompanied by decreased
expression levels of TAZ and MSX2, while ID1 showed no
change, whereas miR-17-5p inhibitor increased the expression
of those proteins, which was consistent with the effects
of siRNA for BMP2. Those results confirmed that miR-17-5p
and miR-106a mediated the commitment of hADSCs between
adipogenesis and osteogenesis directly through targeting
Figure 6 The effects of endogenous BMP2 downregulation in hADSCs are consistent with that of miR-17-5p and miR-106a
overexpression on osteogenic and adipogenic differentiation. (A) The efficiency of BMP2 siRNAs was confirmed by ELISA and western
blot. Three pairs of siRNA, named as siB1, siB2, and siB3, and their negative control (siNC) were compared for the downregulated-
efficiency of BMP2 protein. The first pair (siB1) was confirmed as the most efficient one and used in following experiments.
(B) Downregulation of endogenous BMP2 in hADSCs suppressed osteogenic differentiation and increased adipogenic lineage,
confirmed by ALP and alizarin red staining, and oil red O staining, respectively. (C) Expression level of osteogenic and adipogenic
associated genes was verified by qRT-PCR during differentiation of siBMP2-transfected hADSCs. (D) Cotransfected siBMP2 with
inhibitor of miR-17-5p reversed the effects of downregulation of miR-17-5p on hADSC differentiation indicated by ALP and alizarin red
staining, and oil red O staining. ALP positive cell number was analysis by image pro plus 6.0 and normalized by total cell number. Oil
red O staining was extracted by isopropanol and quantified by OD value at 510 nm wavelength. (E) Western blot confirmation that
miR-17-5p targets the BMP2, followed by the decrease of its downstream. Relative mRNA/protein levels are represented as mean±
SEM. GAPDH was used for mRNA data normalization. GAPDH or Actin was used for protein data normalization. Data are presented as
a mean with a standard error from three independent repeats. A Student's T test was performed for a control and the treatment. The
significance difference is noted as ***, pb0.001; **, pb0.01; *, pb0.05, respectively.
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Figure 7 miR-17-5p and miR-106a regulate adipogenic and
osteogenic differentiation of hADSCs by activating the TAZ/
Msx2-Runx2/PPARγ pathway.
miR-17-5p and miR-106a in osteogenic and adipogenic differentiation 323BMP2 and then participating in MSX2/TAZ regulated Runx2
and PPARγ pathway. Our studies elucidate the mechanisms
underlying selective induction of a tissue specific phenotype
bymiR-17-5p andmiR-106a. Thus these findings could improve
hADSCs-based cell therapy for osteogenesis- and adipogenesis-
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